|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
Click here for printer friendly page
Weekly Deals and Funds Roundup: 20 July 200520/07/2005. Source: AltAssets. 
 A selection of the latest deal and fund news from across the globe - essential reading for those who need to keep up-to-date with the industry's key developments.
This weekly roundup provides an update on smaller deals and fund activity that did not feature as separate stories in AltAssets' daily news service.
DEALS
21 Centrale Partners, the French subsidiary of Alessandro Benetton's 21 Investimenti, has bought Holophane, a French producer of glass covers for car lighting, in a secondary buy-out managed by Gérard Pluvinet, CEO, and Stéphane Perriquet, partner of 21 Centrale Partners. Centrale Partners acquired 72 per cent of Holophane, while the management holds the remaining 28 per cent. A group of French private equity investors led by Natexis Industrie sold their shareholding on this occasion.
Dice, a provider of online recruiting services for technology, engineering and security-cleared professionals, has announced that General Atlantic and Quadrangle Group have agreed to acquire the company's equity. The management team will continue to lead the company and remain significant equity holders. The two private equity firms are equal partners in the transaction.
American Capital Strategies has invested in Compusearch Software Systems, a provider of e-procurement solutions and services to the federal government. The firm's investment takes the form of senior term loans, senior subordinated debt and convertible preferred equity and supports Carlyle Venture Partners' acquisition of Compusearch. American Capital is also providing a revolving credit facility. American Capital is a publicly traded buy-out and mezzanine fund with capital resources of approximately $5.4bn.
FUNDS
UK-based venture capital firm Abingworth Management has held a $53m first close on its new fund, Abingworth BioEquities Fund. This is its seventh life sciences fund and the first dedicated solely to investments in quoted stocks.
Copyright © 2005 AltAssets
|
 
|
|
|
